AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Romero, P Dutoit, V Rubio-Godoy, V Lienard, D Speiser, D Guillaume, P Servis, K Rimoldi, D Cerottini, JC Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S

Authors: Pittet, MJ Speiser, DE Lienard, D Valmori, D Guillaume, P Dutoit, V Rimoldi, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S

Authors: de Seze, J Dubucquoi, S Lefranc, D Virecoulon, F Nuez, I Dutoit, V Vermersch, P Prin, L
Citation: J. De Seze et al., IgG reactivity against citrullinated myelin basic protein in multiple sclerosis, J NEUROIMM, 117(1-2), 2001, pp. 149-155

Authors: Rubio-Godoy, V Dutoit, V Rimoldi, D Lienard, D Lejeune, F Speiser, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307

Authors: Dietrich, PY Walker, PR Quiquerez, AL Perrin, G Dutoit, V Lienard, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: Py. Dietrich et al., Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptidewith diverse and nonoverlapping T-cell receptor repertoires, CANCER RES, 61(5), 2001, pp. 2047-2054

Authors: Valmori, D Dutoit, V Rubio-Godoy, V Chambaz, C Lienard, D Guillaume, P Romero, P Cerottini, JC Rimoldi, D
Citation: D. Valmori et al., Frequent cytolytic T-cell responses to peptide IMAGE-A10(254-262) in melanoma, CANCER RES, 61(2), 2001, pp. 509-512

Authors: Dutoit, V Rubio-Godoy, V Dietrich, PY Quiqueres, AL Schnuriger, V Rimoldi, D Lienard, D Speiser, D Guillaume, P Batard, P Cerottini, JC Romero, P Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856

Authors: Pinilla, C Rubio-Godoy, V Dutoit, V Guillaume, P Simon, R Zhao, YD Houghten, RA Cerottini, JC Romero, P Valmori, D
Citation: C. Pinilla et al., Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, CANCER RES, 61(13), 2001, pp. 5153-5160

Authors: Rimoldi, D Rubio-Godoy, V Dutoit, V Lienard, D Salvi, S Guillaume, P Speiser, D Stockert, E Spagnoli, G Servis, C Cerottini, JC Lejeune, F Romero, P Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261

Authors: Valmori, D Dutoit, V Lienard, D Lejeune, F Speiser, D Rimoldi, D Cerundolo, V Dietrich, PY Cerottini, JC Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538

Authors: Valmori, D Dutoit, V Lienard, D Rimoldi, D Pittet, MJ Champagne, P Ellefsen, K Sahin, U Speiser, D Lejeune, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, CANCER RES, 60(16), 2000, pp. 4499-4506
Risultati: 1-11 |